Volume 12, Issue 16 (5-2022)
JNIP 2022, 12(16): 1-14 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Fallah K, Sotoudeh Asl N. Evaluation of quality of life and life expectancy in female patients with skin cancer undergoing chemotherapy. JNIP 2022; 12 (16) :1-14
URL: http://jnip.ir/article-1-681-en.html
URL: http://jnip.ir/article-1-681-en.html
Associate professor ،department of Psychology، Semnan Branch، Islamic Azad، University، Semnan ،Iran
Abstract: (1345 Views)
The aim of this study was to evaluate the rate of hope and quality of life in female patients with skin cancer undergoing chemotherapy. Descriptive cross-sectional research method that was performed in 2021 on 130 of this population of patients undergoing chemotherapy in hospitals in Mashhad. Due to the presence of 176 female patients with skin cancers, all of them were selected by census, of which only 130 people completed the questionnaires, so the same number were selected to complete the questionnaire. The data collection tool in this study was the standard questionnaire of quality of life questionnaire (WHOQOL-BREF) and Miller life expectancy. Descriptive statistics (mean and standard deviation) and inferential statistics (Chi-square test) were used to analyze the data. The results showed that the rate of hope and quality of life in female patients with skin cancers undergoing chemotherapy is lower than the average population. Also, women with higher education, better economic conditions and married were more hopeful than other people with the disease. These factors had no significant relationship with the quality of life of female patients with skin cancer undergoing chemotherapy.
Type of Study: Research |
Subject:
Special
Received: 2022/06/6 | Revised: 2022/06/8 | Accepted: 2022/05/31 | Published: 2022/05/31
Received: 2022/06/6 | Revised: 2022/06/8 | Accepted: 2022/05/31 | Published: 2022/05/31
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
